Latest news from across the biotech industry
First-in-human, open-label, dose escalation study will evaluate ZB131 in patients who have solid tumors with high CSP expression.
The net proceeds of the offering strengthen Adial’s balance sheet as it moves toward completion of the Company’s Phase 3 ONWARD™ trial.
Virginia’s life sciences ecosystem includes more than 1,400 companies that employ more than 26,500 people.
As a domain expert in applications of diagnostic ultrasound imaging, Dr. Sheeran will lead projects primarily focused on Accuro XV CADe/x algorithm development and testing at RIVANNA.
Company leadership expansion includes appointment of Ramesh K. Ramanathan as new vice president for clinical development.
Patent covers patients with a specific genetic biomarker for the serotonin-3 receptor.
Molecular Biologicals is utilizing bioactive keratin to heal chronic wounds better and faster.
ASR Group – exclusive sales and distribution partner – reports strong customer demand for the unique, rare sugar, accelerating the timeline for a second production plant.
RIVANNA to invest $260,000 to renovate facility and more than double its workforce.
Industry Veteran Will Lead HST5040 and Future Rare Disease Clinical Program.
Through engagement, resourcing, and educational tools, CvilleBioHub has consistently added significant value to the growing community.
Diffusion announced that its near-term focus will be the design and execution of a clinical program to support the use of intravenously administered TSC as a treatment for hypoxic tumors.